Rate Video

ESH MM 2018 | Early detection and intervention in myeloma: a critical point

Jesús San Miguel • 5 Oct 2018

ESH MM 2018

Multiple Myeloma

While our treatments for multiple myeloma (MM) are improving all the time, the best time to eradicate disease is early on. Here, Jesús San Miguel, MD, PhD, of the University of Navarra, Pamplona, Spain, discusses the importance of early intervention from the European School of Haematology (ESH) International Conference on MM 2018, held in Mandelieu, France.

New tools for multiple myeloma treatment monitoring

Bruno Paiva et al. • 16 Sep 2016

The future of myeloma therapy and where the treatment landscape is moving

Jesús San Miguel • 13 May 2022

Challenges in the treatment of multiple myeloma

Jesús San Miguel • 12 Jun 2015

Overview and rationale for practical workshops at the 2016 European Multiple Myeloma Academy (EMMA)

Jesús San Miguel • 16 Sep 2016

Related Videos

A.R.R.O.W. study: carfilzomib dosing in frail MM patients

Maria-Victoria Mateos

Managing CRS in myeloma

Managing transplant patients during the COVID-19 pandemic

Christian Chabannon

DNA methyltransferase inhibitors: daratumumab enhancement for MM